{
  "nctId": "NCT02725008",
  "briefTitle": "Trial of One Versus Two Doses of Dexamethasone for Pediatric Asthma Exacerbation",
  "officialTitle": "A Randomized Double Blinded Placebo Controlled Trial of One Versus Two Doses of Oral Dexamethasone for the Treatment of Acute Asthma Exacerbation in the Pediatric Emergency Department (ED)",
  "protocolDocument": {
    "nctId": "NCT02725008",
    "filename": "Prot_SAP_000.pdf",
    "label": "Study Protocol and Statistical Analysis Plan",
    "date": "2015-02-13",
    "uploadDate": "2018-11-30T08:36",
    "size": 161403,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT02725008/document/Prot_SAP_000.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": false
  },
  "phase": [
    "PHASE3"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "RANDOMIZED",
  "interventionModel": "PARALLEL",
  "masking": "QUADRUPLE",
  "enrollmentInfo": {
    "enrollmentCount": 99,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2015-11",
    "completionDate": "2017-11",
    "primaryCompletionDate": "2017-11",
    "firstSubmitDate": "2016-03-18",
    "firstPostDate": "2016-03-31"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* History of asthma defined as at least two (2) prior episodes of respiratory illness characterized by wheezing treated with inhaled beta agonists\n\nExclusion Criteria:\n\n* pregnancy\n* severe chronic cardiac, respiratory, neurological or neuromuscular disease\n* complete resolution of symptoms after one treatment of beta agonists\n* severe asthma symptoms as defined by a Pulmonary Index Score of 12 or greater",
    "healthyVolunteers": false,
    "sex": "ALL",
    "minimumAge": "18 Months",
    "maximumAge": "20 Years",
    "stdAges": [
      "CHILD",
      "ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Treatment Failure",
        "description": "number of patients who experience any of the following outcomes - unplanned hospital admission for asthma symptoms, unplanned ED visit for asthma symptoms, unplanned urgent care visit for asthma symptoms, unplanned primary care physician visit for asthma symptoms, or prescription of a course of steroids",
        "timeFrame": "5 days"
      }
    ],
    "secondary": [
      {
        "measure": "Change in Symptom Severity From Day 1 to Day 5",
        "description": "Severity of asthma symptoms as reported by the Patient Self Assessment Score. Patients assessed severity of asthma symptoms in 4 categories (wheezing, coughing, activity and sleep) once per day during the 5 days between study enrollment and follow-up. Score range is 0 - 12 with 0 being mildest symptoms and 12 being most severe symptoms. Reported as change in score between enrollment (day 1) and follow-up (day 5).",
        "timeFrame": "5 days"
      }
    ],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 1,
      "secondaryCount": 1,
      "otherCount": 0,
      "totalCount": 2
    },
    "studyDesign": {
      "phases": [
        "PHASE3"
      ],
      "isRandomized": true,
      "isMasked": true,
      "interventionModel": "PARALLEL"
    },
    "overallComplexityScore": 44,
    "complexityCategory": "Moderate"
  },
  "collectionDate": "2025-09-22T02:29:21.305Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}